Rid­ing the wave on lat­est obe­si­ty buy­out; Slack in­ter­view with an­ti-ag­ing re­searcher; Two new IRA law­suits; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

As sum­mer comes to an end, we are get­ting ready to launch a fresh back-to-school look for the End­points Week­ly. Thanks as al­ways for your read­er­ship, and stay tuned!

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.